Stock search

Ticker or company name

Compare stocks

Market: US

  • BDXBecton Dickinson
  • EWEdwards Lifesciences
  • IDXXIdexx Laboratories

Add stock

Ticker or company

Summary

BDX
Becton Dickinson
$216,47Down −0,72%
Year: Up +44%
38/100Ratio would not consider buying
Open stock page
EW
Edwards Lifesciences
$107,11Down −0,04%
Year: Up +24%
56/100Ratio would watch
Open stock page
IDXX
Idexx Laboratories
$700,65Down −0,51%
Year: Up 0%
83/100Best scoreRatio would consider buying
Open stock page

Verdict

IDXX has the best score (83). EW grows revenue the fastest. BDX is the cheapest by forward P/E. EW has the lowest debt load. IDXX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBDX2 ✓ 2 — 4 ✕EW5 ✓ 0 — 4 ✕IDXX7 ✓ 1 — 1 ✕
P/E vs its history51,860,347,2
P/E vs industry51,860,347,2
Forward P/E14,935,533,5
Revenue growth, YoY−2,6%+13,4%+11,9%
EPS growth, YoY−39,4%−23,7%+17,7%
Net margin4,5%15,2%25,4%
Net debt / EBITDA2,9−2,50,1
Free cash flown/a—$1,42 bn$1,30 bn
Share count over a year−4,2%−1,4%−2,0%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBDXTTMEWTTMIDXXTTMIndustry medianTTM
P/E TTM ↓51,8Worst: 60,3Best: 47,225,1
Forward P/E ↓Best: 14,9Worst: 35,533,516,2
PEG ↓−27,1n/a2,82,2
P/S TTM ↓Best: 2,99,2Worst: 12,02,2
EV/EBITDA ↓Best: 16,4Worst: 43,833,917,3
P/FCF ↓Best: 21,542,6Worst: 42,919,5

Price, %

  • BDXn/a
  • EWn/a
  • IDXXn/a

Returns

Best WorstNo mark — in between

PeriodBDXEWIDXX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BDXEWIDXX
Share of “buy”Worst: 57%Best: 82%67%
Beat the forecastBest: 4 of 4Worst: 3 of 4Best: 4 of 4
Average “surprise”+2,2%Worst: +0,7%Best: +3,7%
Insiders over 12 monthssales $3,38 msales $34,0 msales $58,4 m

Details are on each stock page.